Technical Analysis for CLYM - Climb Bio, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | -5.19% | |
Oversold Stochastic | Weakness | -5.19% | |
Slingshot Bearish | Bearish Swing Setup | -10.15% | |
MACD Bullish Signal Line Cross | Bullish | -10.15% | |
Wide Bands | Range Expansion | -10.15% | |
Oversold Stochastic | Weakness | -10.15% | |
MACD Bearish Signal Line Cross | Bearish | -4.58% | |
NR7 | Range Contraction | -4.58% | |
Wide Bands | Range Expansion | -4.58% | |
Oversold Stochastic | Weakness | -4.58% |
Alert | Time |
---|---|
Down 5% | about 2 hours ago |
Down 3% | about 2 hours ago |
Fell Below Previous Day's Low | about 2 hours ago |
Down 2 % | about 2 hours ago |
Down 1% | about 2 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wilmington, DE.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Molecular Biology Gene Therapy Immune Mediated Diseases Bioethics
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Molecular Biology Gene Therapy Immune Mediated Diseases Bioethics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.55 |
52 Week Low | 2.35 |
Average Volume | 606,046 |
200-Day Moving Average | 5.62 |
50-Day Moving Average | 5.10 |
20-Day Moving Average | 3.69 |
10-Day Moving Average | 3.43 |
Average True Range | 0.36 |
RSI (14) | 31.03 |
ADX | 42.02 |
+DI | 12.71 |
-DI | 27.81 |
Chandelier Exit (Long, 3 ATRs) | 3.78 |
Chandelier Exit (Short, 3 ATRs) | 4.08 |
Upper Bollinger Bands | 4.53 |
Lower Bollinger Band | 2.84 |
Percent B (%b) | 0.14 |
BandWidth | 45.76 |
MACD Line | -0.52 |
MACD Signal Line | -0.53 |
MACD Histogram | 0.0112 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.51 | ||||
Resistance 3 (R3) | 3.55 | 3.44 | 3.44 | ||
Resistance 2 (R2) | 3.44 | 3.33 | 3.42 | 3.41 | |
Resistance 1 (R1) | 3.26 | 3.26 | 3.21 | 3.22 | 3.39 |
Pivot Point | 3.16 | 3.16 | 3.13 | 3.14 | 3.16 |
Support 1 (S1) | 2.98 | 3.05 | 2.92 | 2.94 | 2.77 |
Support 2 (S2) | 2.87 | 2.98 | 2.85 | 2.75 | |
Support 3 (S3) | 2.69 | 2.87 | 2.72 | ||
Support 4 (S4) | 2.65 |